These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7995001)

  • 1. Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole.
    Varhe A; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):601-7. PubMed ID: 7995001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.
    Olkkola KT; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 1994 May; 55(5):481-5. PubMed ID: 8181191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itraconazole greatly increases plasma concentrations and effects of felodipine.
    Jalava KM; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Apr; 61(4):410-5. PubMed ID: 9129558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism.
    Varhe A; Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1996 Apr; 41(4):319-23. PubMed ID: 8730978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ingestion time interval on the interaction between itraconazole and triazolam.
    Neuvonen PJ; Varhe A; Olkkola KT
    Clin Pharmacol Ther; 1996 Sep; 60(3):326-31. PubMed ID: 8841155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
    Greenblatt DJ; Wright CE; von Moltke LL; Harmatz JS; Ehrenberg BL; Harrel LM; Corbett K; Counihan M; Tobias S; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam.
    Backman JT; Wang JS; Wen X; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1999 Oct; 66(4):401-7. PubMed ID: 10546924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole.
    Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Sep; 62(3):348-54. PubMed ID: 9333111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diltiazem enhances the effects of triazolam by inhibiting its metabolism.
    Varhe A; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1996 Apr; 59(4):369-75. PubMed ID: 8612379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced effect of triazolam with diltiazem.
    Kosuge K; Nishimoto M; Kimura M; Umemura K; Nakashima M; Ohashi K
    Br J Clin Pharmacol; 1997 Apr; 43(4):367-72. PubMed ID: 9146848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itraconazole increases plasma concentrations of quinidine.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Nov; 62(5):510-7. PubMed ID: 9390107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice.
    Hukkinen SK; Varhe A; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1995 Aug; 58(2):127-31. PubMed ID: 7648762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.
    Granfors MT; Backman JT; Neuvonen M; Ahonen J; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Apr; 75(4):331-41. PubMed ID: 15060511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluconazole dose on the extent of fluconazole-triazolam interaction.
    Varhe A; Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1996 Oct; 42(4):465-70. PubMed ID: 8904618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triazolam is ineffective in patients taking rifampin.
    Villikka K; Kivistö KT; Backman JT; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Jan; 61(1):8-14. PubMed ID: 9024169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of antimycotic itraconazole on the pharmacokinetics or pharmacodynamics of temazepam.
    Ahonen J; Olkkola KT; Neuvonen PJ
    Ther Drug Monit; 1996 Apr; 18(2):124-7. PubMed ID: 8721273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
    Varis T; Kivistö KT; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo.
    Villikka K; Varis T; Backman JT; Neuvonen PJ; Kivistö KT
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):457-60. PubMed ID: 11699609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: repeated consumption prolongs triazolam half-life.
    Lilja JJ; Kivistö KT; Backman JT; Neuvonen PJ
    Eur J Clin Pharmacol; 2000 Aug; 56(5):411-5. PubMed ID: 11009051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.